Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bonnotte

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
La Revue De Medecine Interne|May 29, 2021
[A positive outcome of the first SNFMI e-congress]B Bonnotte
La Revue De Medecine Interne|September 15, 2004
[Pathogenic mechanisms of autoimmune diseases]B Bonnotte
La Revue De Medecine Interne|November 2, 2010
[Pathogenic mechanisms of autoimmune diseases]B Bonnotte
La Revue De Medecine Interne|December 2, 2015
[Pathogenesis of large vessel vasculitis]M Samson, B Bonnotte
La Revue De Medecine Interne|August 13, 2023
[What about the new ACR/EULAR classification criteria for giant cell arteritis?]M Samson, B Bonnotte
La Revue De Medecine Interne|August 13, 2017
[From pathogenesis of giant cell arteritis to new therapeutic targets]M Samson, B Bonnotte
La Revue De Medecine Interne|February 25, 2022
[How to apply the EULAR and ACR recommendations for the diagnosis and treatment of giant cell arteritis?]M Samson, B Bonnotte
La Revue De Medecine Interne|December 9, 2017
[Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?]M Samson, B Bonnotte
Presse Medicale (Paris, France : 1983)|January 20, 1999
[Anticancer chemotherapy. Prevention of toxicity]G Chvetzoff, B Bonnotte, B Chauffert
La Revue De Medecine Interne|July 28, 2020
[Challenges and potential solutions in first-line treatments for immune thrombocytopenia in adults]B Godeau, B Bonnotte, M Michel
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
La Revue De Medecine Interne|May 29, 2021
[A positive outcome of the first SNFMI e-congress]B Bonnotte
La Revue De Medecine Interne|September 15, 2004
[Pathogenic mechanisms of autoimmune diseases]B Bonnotte
La Revue De Medecine Interne|November 2, 2010
[Pathogenic mechanisms of autoimmune diseases]B Bonnotte
La Revue De Medecine Interne|December 2, 2015
[Pathogenesis of large vessel vasculitis]M Samson, B Bonnotte
La Revue De Medecine Interne|August 13, 2023
[What about the new ACR/EULAR classification criteria for giant cell arteritis?]M Samson, B Bonnotte
La Revue De Medecine Interne|August 13, 2017
[From pathogenesis of giant cell arteritis to new therapeutic targets]M Samson, B Bonnotte
La Revue De Medecine Interne|February 25, 2022
[How to apply the EULAR and ACR recommendations for the diagnosis and treatment of giant cell arteritis?]M Samson, B Bonnotte
La Revue De Medecine Interne|December 9, 2017
[Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?]M Samson, B Bonnotte
Presse Medicale (Paris, France : 1983)|January 20, 1999
[Anticancer chemotherapy. Prevention of toxicity]G Chvetzoff, B Bonnotte, B Chauffert
La Revue De Medecine Interne|July 28, 2020
[Challenges and potential solutions in first-line treatments for immune thrombocytopenia in adults]B Godeau, B Bonnotte, M Michel
Pageof 8